DK373782A - Fremgangsmaade til fremstilling af hidtil ukendte pyrimidin- eller s-triazinderivater - Google Patents

Fremgangsmaade til fremstilling af hidtil ukendte pyrimidin- eller s-triazinderivater Download PDF

Info

Publication number
DK373782A
DK373782A DK373782A DK373782A DK373782A DK 373782 A DK373782 A DK 373782A DK 373782 A DK373782 A DK 373782A DK 373782 A DK373782 A DK 373782A DK 373782 A DK373782 A DK 373782A
Authority
DK
Denmark
Prior art keywords
pyrimidine
procedure
triazine derivatives
unknown
preparing
Prior art date
Application number
DK373782A
Other languages
Danish (da)
English (en)
Inventor
Pietro Gomarasca
Carlo Scolastico
Cesare Sirtori
Original Assignee
Lpb Ist Farm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lpb Ist Farm filed Critical Lpb Ist Farm
Publication of DK373782A publication Critical patent/DK373782A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40Nitrogen atoms
    • C07D251/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40Nitrogen atoms
    • C07D251/42One nitrogen atom
    • C07D251/44One nitrogen atom with halogen atoms attached to the two other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40Nitrogen atoms
    • C07D251/42One nitrogen atom
    • C07D251/46One nitrogen atom with oxygen or sulfur atoms attached to the two other ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK373782A 1981-08-20 1982-08-20 Fremgangsmaade til fremstilling af hidtil ukendte pyrimidin- eller s-triazinderivater DK373782A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8123580A IT1211096B (it) 1981-08-20 1981-08-20 Pirimidine e s.triazinici adattivita' ipolipidemizzante.

Publications (1)

Publication Number Publication Date
DK373782A true DK373782A (da) 1983-02-21

Family

ID=11208290

Family Applications (1)

Application Number Title Priority Date Filing Date
DK373782A DK373782A (da) 1981-08-20 1982-08-20 Fremgangsmaade til fremstilling af hidtil ukendte pyrimidin- eller s-triazinderivater

Country Status (9)

Country Link
US (1) US4559345A (ja)
EP (1) EP0073328A1 (ja)
JP (1) JPS5869870A (ja)
CA (1) CA1173036A (ja)
DE (1) DE73328T1 (ja)
DK (1) DK373782A (ja)
ES (3) ES8401037A1 (ja)
IT (1) IT1211096B (ja)
PH (1) PH17607A (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK130584A (da) * 1983-04-08 1984-10-09 Ciba Geigy Ag N-(2-nitrophenyl)-4-amino-pyrimidin-derivater samt deres fremstilling og anvendelse som mikrobicider
US4542216A (en) * 1984-03-27 1985-09-17 Ciba Geigy Corporation Process for producing fluoroalkoxyaminopyrimidines
DE3445293A1 (de) * 1984-12-12 1986-06-12 Bayer Ag, 5090 Leverkusen Neue 2,4-diaminopyrimidine
JPH0631238B2 (ja) * 1985-08-01 1994-04-27 日産化学工業株式会社 ピラゾロ〔4,3−d〕ピリミジン誘導体
GB8911287D0 (en) * 1989-05-17 1989-07-05 Ciba Geigy Ag Lubricant compositions
DE4104466A1 (de) * 1990-03-09 1991-09-12 Huels Chemische Werke Ag Quartaere ammoniumsalze von thiobarbitursaeuren und verfahren zu deren herstellung
ATE401312T1 (de) 1997-12-15 2008-08-15 Astellas Pharma Inc Pyrimidin-5-carboxamid-derivate
AR035838A1 (es) 1999-01-22 2004-07-21 Elan Pharm Inc Compuestos multiciclicos que inhiben la adhesion de leucocitos mediada por vla-4 y el uso de los mismos para la preparacion de un medicamento
CN1336921A (zh) 1999-01-22 2002-02-20 依兰制药公司 抑制vla-4介导的白细胞粘附的稠合环杂芳基和杂环化合物
DK1144388T3 (da) * 1999-01-22 2010-05-25 Elan Pharm Inc Acyl-derivater, som behandler VLA-4-relaterede lidelser
US6436904B1 (en) * 1999-01-25 2002-08-20 Elan Pharmaceuticals, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
JP2002538135A (ja) 1999-03-01 2002-11-12 エラン ファーマシューティカルズ,インコーポレイテッド α4β7レセプターアンタゴニストとして有用なα−アミノ酢酸誘導体
EP1341773A2 (en) 2000-12-07 2003-09-10 Cv Therapeutics, Inc. Substituted 1,3,5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
JP2005501817A (ja) * 2001-06-12 2005-01-20 アクティブ パス ファーマシューティカルズ, インコーポレイテッド β−アミロイド産生を調節する化合物、組成物および方法
TW200307671A (en) * 2002-05-24 2003-12-16 Elan Pharm Inc Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
TWI281470B (en) * 2002-05-24 2007-05-21 Elan Pharm Inc Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
DE102005025161A1 (de) * 2005-06-01 2006-12-07 Phenion Gmbh & Co. Kg Derivate des Pyrimidins und Triazins und deren Verwendung
KR20080059268A (ko) * 2005-09-29 2008-06-26 엘란 파마슈티칼스, 인크. Vla-4에 의해 매개되는 백혈구 부착을 억제하는피리미디닐 아미드 화합물
ATE502031T1 (de) 2005-09-29 2011-04-15 Elan Pharm Inc Carbamatverbindungen, die die durch vla-4 vermittelte leukozytenadhäsion inhibieren
CA2643838A1 (en) * 2006-02-27 2007-09-07 Elan Pharmaceuticals, Inc. Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4
CA2760151A1 (en) * 2009-04-27 2010-11-04 Elan Pharmaceuticals, Inc. Pyridinone antagonists of alpha-4 integrins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB744867A (en) * 1952-10-29 1956-02-15 American Cyanamid Co Improvements relating to 2-substituted-mercapto-4-amino-6-disubstituted-aminopyrimidines and acid addition salts thereof
US3321478A (en) * 1963-09-20 1967-05-23 American Cyanamid Co Aminoethoxyphenyl amine, ether, and sulfide derivatives of pyrimidine
FR1413722A (fr) * 1963-11-12 1965-10-08 Geigy Ag J R Nouveaux dérivés de la pyrimidine, leur préparation et leurs applications
CH481986A (de) * 1967-05-24 1969-11-30 Geigy Ag J R Verfahren zur Herstellung von wasserlöslichen Farbsalzen von Azopyrimidinfarbstoffen
US3814761A (en) * 1972-03-31 1974-06-04 American Home Prod (2-pyrimidinylthio)alkanoic acids,esters,amides and hydrazides
US3974162A (en) * 1972-12-21 1976-08-10 American Home Products Corporation 4-Pyrimidinylthioacetic acid derivatives
DE2549161A1 (de) * 1975-11-03 1977-05-12 Henkel & Cie Gmbh Farbentwickler fuer farbphotographische entwicklungsverfahren
IT1063074B (it) * 1976-03-17 1985-02-11 Lpb Ist Farm Ammidi di acidi(z-pirimidiniltio)al canoici quali agent antilipemici

Also Published As

Publication number Publication date
ES8500912A1 (es) 1984-11-16
DE73328T1 (de) 1983-07-21
ES515104A0 (es) 1983-12-16
IT8123580A0 (it) 1981-08-20
ES524185A0 (es) 1985-05-01
US4559345A (en) 1985-12-17
PH17607A (en) 1984-10-05
CA1173036A (en) 1984-08-21
ES524186A0 (es) 1984-11-16
EP0073328A1 (en) 1983-03-09
ES8401037A1 (es) 1983-12-16
ES8504741A1 (es) 1985-05-01
JPS5869870A (ja) 1983-04-26
IT1211096B (it) 1989-09-29

Similar Documents

Publication Publication Date Title
DK373782A (da) Fremgangsmaade til fremstilling af hidtil ukendte pyrimidin- eller s-triazinderivater
DK50482A (da) Fremgangsmaade til fremstilling af quinazolinderivater
DK112582A (da) Fremgangsmaade til fremstilling af triazolonderivater
DK491682A (da) Fremgangsmaade til fremstilling af substituerede benzimidazoler
DK66582A (da) Fremgangsmaade til fremstilling af carbostyrilderivater
DK84082A (da) Fremgangsmaade til fremstilling af pg12-derivater
DK354482A (da) Fremgangsmaade til fremstilling af substituerede pyridazinderivater
DK491582A (da) Fremgangsmaade til fremstilling af morphinanderivater
DK453882A (da) Fremgangsmaade til fremstilling af triazinderivater
DK241982A (da) Fremgangsmaade til fremstilling af carboximidderivater
DK364181A (da) Fremgangsmaade til fremstilling af caprolactamderivater
DK501181A (da) Fremgangsmaade til fremstilling af 2-substituerede benzofuranderivater
DK150070C (da) Analogifremgangsmaade til fremstilling af n-dihydrothiazolyl-3-quinolincarboxamidderivater
DK358782A (da) Fremgangsmaade til fremstilling af pyridazinderivater
DK312082A (da) Fremgangsmaade til fremstilling af benzothiazolsulfonamidderivater
DK160555C (da) Fremgangsmaade til fremstilling af eburnamoninderivater
DK156722C (da) Analogifremgangsmaade til fremstilling af 2-piperazinopyrimidinderivater
DK116982A (da) Fremgangsmaade til fremstilling af alkylendioxybenzenderivater
DK316881A (da) Fremgangsmaade til fremstilling af quinazolinderivater
DK553582A (da) Fremgangsmaade til fremstilling af naphthoxyalkylaminer
DK252981A (da) Fremgangsmaade til fremstilling af pyrimidinderivater
DK314682A (da) Fremgangsmaade til fremstilling af substituerede thiazolo-(3,2-a)pyrimidiner
DK372081A (da) Fremgangsmaade til fremstilling af fluorerede pentendiaminderivater
DK4982A (da) Fremgangsmaade til fremstilling af pyridinylsubstituerede benzimidazolderivater
DK375882A (da) Fremgangsmaade til fremstilling af benzisoxazolderivater